Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.

Bishop, R.T., Marino, S., de Ridder, D. et al. (6 more authors) (2019) Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Letters, 450. pp. 76-87. ISSN 0304-3835

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Elsevier B.V. This is an author produced version of a paper subsequently published in Cancer Letters. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Bone; Bone metastasis; Breast cancer; Combination treatment; IKKε; NFκB; Osteoblast; Osteoclast; Osteolysis
Dates:
  • Accepted: 14 February 2019
  • Published (online): 18 February 2019
  • Published: 28 May 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 26 Apr 2019 13:30
Last Modified: 26 Apr 2019 13:30
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.canlet.2019.02.032
Related URLs:

Download

Accepted Version


Embargoed until: 18 February 2020

Filename: Bishop, Idris et al - Can Lett - IKKe & BCa.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

Share / Export

Statistics